TheLock&EarnSCTwillbelaunchedatthe"Lock&Earn"ofGate.ioHODL&Earnat2023-4-138:00UTC.Itsinterestrateis150%APRandtheinvestmenttermis14days.
Howtosubscribe:
App:ClickMarkets>Hodl&Earn>Lock&Earn
EarnNow:https://www.gate.io/hodl/1725
Gate.io Startup首发项目PNL已认购成功:据官方公告,Gate.io Startup首发项目TruePNL (PNL)已认购成功,并已于5月19日01:30 开通PNL交易并随后开通提现服务。据悉,本次认购参与人数共有18,049人,下单总价值超过1,000万美金,认购系数约为0.0025。Gate.io将根据每个人的下单情况和每个下单币种的认购系数进行PNL的分发。请务必注意:由于部分用户在下单认购后到当天24点之前,没有保持账户中有不低于认购金额的足够金额,因此被排除在有下单之外。[2021/5/19 22:17:49]
JointheGateEarnTelegramGrouptolearnmore.
Gate.io 已完成12月13日FIL代币转化分发,总量约1.3万枚:据官方公告,Gate.io今日(12月13日)已经根据用户FIL6持仓情况完成FIL分发,总计约1.3万枚,用户可在账户账单明细中查看详情。目前Gate.io已经支持Filecoin(FIL)现货交易,充值提现,杠杆交易,币币理财,永续合约交易,三倍ETF交易等全线系列产品和服务。[2020/12/13 15:03:47]
RulesofLock-up&EarnSCT(14days)
1.StartPosition:20SCT
Gate.io上线XAUG永续合约交易(USDT结算):据官网公告,Gate.io已上线XAUG/USDT永续合约实盘及模拟盘交易(USDT结算),支持1-20倍做多和做空操作,杠杆率可以在下单时自行选择。Gate.io永续合约目前日交易量高达8亿美金,结算类型分为“BTC结算永续合约”和“USDT结算永续合约”两种。[2020/8/8]
2.MaximumPosition:3580SCT
3.StartTime:2023-4-138:00UTC
*Theprincipalandinterestwillbedistributedwhenthelock-upperiodends
SuperCellsToken(SCT)
SuperCellsistheworld'sfirstblockchain-basedStemCellmembershipserviceecology,creatingametaverseofStemCellstorage,cultivation,R&D,trading,serviceandincubation.SuperCellsbuildsafour-in-onemetaverseecologyofdemand,service,communityandsupervision,andusesblockchaintoeconomizeusers'participationbehaviorsandpromotetherapiddevelopmentoftheStemCellindustrychaintocontributetothecauseofhumanhealth.
GatewaytoCrypto
Tradeover1,400cryptocurrenciessafely,quicklyandeasilyonGate.io
Signuptoenterthecryptogatewayandget40%commissionfromreferrals
DownloadiOS/AndroidApprightnow.
Reachouttous!
Twitter:https://twitter.com/gate_io
GateVIPTwitter:https://twitter.com/GateioVIP
Telegram:https://t.me/gate_io
APITelegram:https://t.me/gateioapi
Instagram:https://www.instagram.com/gateioglobal
Medium:https://gateio.medium.com/
Podcast:https://gateio.buzzsprout.com/?ch=buzzs
Gate.ioTeam
April12th,2023
郑重声明: 本文版权归原作者所有, 转载文章仅为传播更多信息之目的, 如作者信息标记有误, 请第一时间联系我们修改或删除, 多谢。